- Home
- ARTV vs DCTH Comparison
ARTV vs DCTH Comparison
Compare ARTV & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARTV
- DCTH
- Stock Information
- Founded
- ARTV 2019
- DCTH 1988
- Country
- ARTV United States
- DCTH United States
- Employees
- ARTV N/A
- DCTH N/A
- Industry
- ARTV
- DCTH Medical/Dental Instruments
- Sector
- ARTV
- DCTH Health Care
- Exchange
- ARTV NYSE
- DCTH Nasdaq
- Market Cap
- ARTV 351.4M
- DCTH 305.2M
- IPO Year
- ARTV 2024
- DCTH N/A
- Fundamental
- Price
- ARTV $10.06
- DCTH $9.39
- Analyst Decision
- ARTV Strong Buy
- DCTH Strong Buy
- Analyst Count
- ARTV 5
- DCTH 4
- Target Price
- ARTV $21.25
- DCTH $21.50
- AVG Volume (30 Days)
- ARTV 63.3K
- DCTH 445.4K
- Earning Date
- ARTV 11-12-2024
- DCTH 11-08-2024
- Dividend Yield
- ARTV N/A
- DCTH N/A
- EPS Growth
- ARTV N/A
- DCTH N/A
- EPS
- ARTV N/A
- DCTH N/A
- Revenue
- ARTV $2,601,000.00
- DCTH $22,644,000.00
- Revenue This Year
- ARTV N/A
- DCTH $1,562.76
- Revenue Next Year
- ARTV N/A
- DCTH $117.72
- P/E Ratio
- ARTV N/A
- DCTH N/A
- Revenue Growth
- ARTV N/A
- DCTH 945.91
- 52 Week Low
- ARTV $9.68
- DCTH $2.38
- 52 Week High
- ARTV $17.31
- DCTH $12.88
- Technical
- Relative Strength Index (RSI)
- ARTV N/A
- DCTH 40.91
- Support Level
- ARTV N/A
- DCTH $10.11
- Resistance Level
- ARTV N/A
- DCTH $12.88
- Average True Range (ATR)
- ARTV 0.00
- DCTH 0.66
- MACD
- ARTV 0.00
- DCTH -0.23
- Stochastic Oscillator
- ARTV 0.00
- DCTH 12.75
About ARTV ARTIVA BIOTHERAPEUTICS INC
Artiva Biotherapeutics Inc is a biopharmaceutical company. The company is engaged in advancing a pipeline of off-the-shelf, allogeneic NK cell therapies for the treatment of hematologic malignancies or solid tumors. The pipeline program of the company includes Artiva-Funded Trials and Collaborator-Funded Trials.
About DCTH Delcath Systems Inc.
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.